Skip to content
Open access

THE RELATIONSHIP OF FREE ANDROGEN INDEX (FAI) WITH INSULIN RESISTANCE IN DIFFERENT PHENOTYPES OF POLYCYSTIC OVARY SYNDROME

Jul 2026 · Genetics and Molecular Research · 0 citations · 6 references

TL;DR

Phenotype-wise assessment improves the identification of metabolic risk in PCOS and helps in individualized clinical management, as FAI was significantly associated with insulin resistance in women with PCOS.

Abstract

Introduction: Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder affecting women of reproductive age. Hyperandrogenism and Hyperinsulinemia are key features of the syndrome. The present study aimed to assess the association between the free androgen index (FAI) and insulin resistance in different phenotypes of PCOS. Methods: A total of 330 women aged 18–45 years diagnosed with PCOS according to the modified 2003 Rotterdam criteria were included. Participants were classified into phenotypes A, B, C, and D. Clinical, anthropometric, hormonal, biochemical parameters, and ultrasound features of all phenotypes were noted. FAI was calculated as total testosterone/sex hormone binding globulin × 100. Insulin resistance was assessed using homeostatic model assessment of insulin resistance (HOMA-IR). Phenotype wise comparisons and correlations between FAI and HOMA-IR were performed. Results: Phenotype A was the most prevalent 51% followed by B (31%), C (11%), and D (7%). FAI showed a significant positive correlation with HOMA-IR in the overall study population (r = 0.255, P < 0.001). Phenotypes A and D showed significant correlations, whereas phenotypes B and C showed non-significant correlations. High FAI levels were observed in 259 participants (78.48%) and were significantly associated with the PCOS phenotypes (P < 0.001). Biochemical hyperandrogenism was highest in phenotype A, followed by B, C, and absent in phenotype D. Conclusion: FAI was significantly associated with insulin resistance in women with PCOS. Phenotype-wise assessment improves the identification of metabolic risk in PCOS and helps in individualized clinical management.

Read PDF

Similar papers

Open access Sep 2026

Phenotype-Specific Differences in Insulin Resistance and Androgenic Profiles in Polycystic Ovary Syndrome: A Prospective Observational Study

Background and Objectives: Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine and metabolic disorder characterized by distinct phenotypic presentations. This study aimed to compare androgenic and metabolic characteristics across Rotterdam-defined PCOS phenotypes, with particular emphasis on insulin resistanc...

Karolin Ohanoglu Cetinel, Ahmet Cinar, Can Tercan et al. · 0 citations
Open access Sep 2026

Association of prolactin with cardiometabolic risk markers in women with polycystic ovary syndrome: a phenotype-based analysis

Compared with controls, women with PCOS had higher body weight, body-mass index, waist circumference, waist circumference, triglyceride levels, insulin resistance-related parameters, triglyceride-glucose (TyG) Index, lipid accumulation product (LAP), and Atherogenic Index of Plasma (AIP), whereas high-density lipoprote...

Hatice Çalışkan Burgucu, Emel Yılmaz Kaya, Ayşen Yümlü et al. · 0 citations
Open access Aug 2026

EP1439 - ECE_3455 - Body weight strongly influences the metabolic phenotype in women with polycystic ovary syndrome

Obesity is strongly associated with a worse metabolic profile in women with PCOS, characterised by marked insulin resistance and dyslipidaemia, while circulating androgen concentrations are broadly comparable across weight categories.

Sabrina Marville, Nelly Pitteloud, A. Ameti · 0 citations
Open access Aug 2026

Obesity, Insulin Resistance, and Infertility in Women with Polyendocrine Metabolic Ovarian Syndrome: A Retrospective Cohort Study at a Tertiary Referral Medical Center in Qatar

Background: Polyendocrine Metabolic Ovarian Syndrome (PMOS), previously known as Polycystic Ovary Syndrome (PCOS), is one of the most common endocrine disorders affecting women of reproductive age and represents a major cause of infertility worldwide. It is associated with hormonal imbalance, ovulatory dysfunction, and...

Tahani Ibrahim Alotoum, Husam Qush, R. Al-Ghanem et al. · 0 citations
Open access Aug 2026

Metabolic and Hormonal Predictors of Non-Alcoholic Fatty Liver Disease in PCOS/PMOS: A Clinicobiochemical Study

A high prevalence of fatty liver and metabolic–hormonal disturbances in PCOS/PMOS is highlighted, primarily mediated by insulin resistance, hyperandrogenism and unhealthy dietary patterns, which underscore the necessity of early metabolic screening and lifestyle interventions.

S. Ghosh, Ritika Seth, P. Chatterjee et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.